19.05.2016
- Bristol-Myers Squibb (BMS) and AbbVie’s cancer treatment Empliciti has received the green light in Europe to treat multiple myeloma, a blood cancer that develops in the bone marrow...
22.04.2016
- After giving it a priority review in January, the US Food and Drug Administration (FDA) has approved Venclexta (venetoclax), a novel of drug that targets a subset of leukemia...
04.04.2016
- Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...
09.03.2016
- US drug maker AbbVie and Germany’s Boehringer Ingelheim are collaborating to develop and commercialize BI 655066, a potential treatment for psoriasis. The drug is also being...
03.03.2016
- Privately owned German drugmaker Boehringer Ingelheim is talking to AbbVie of the US about a partnership in oncology potentially worth billions of dollars, the news agency...
24.02.2016
- Major drugs firms AstraZeneca, Pfizer and Eli Lilly are among seven of the world’s largest pharmaceutical companies that have joined a new consortium to improve clinical trials for...
19.01.2016
- Venetoclax, a novel leukemia treatment developed by biopharmaceutical company AbbVie, is to be reviewed by regulators in the US and EU. The drug is described as a potential first...
15.12.2015
- AstraZeneca has confirmed speculation that it is “exploring potential strategic options” with Acerta Pharma, a privately owned biotech firm with operations in the Netherlands and...
